bioAffinity Technologies (BIAF) Net Margin (2022 - 2026)
bioAffinity Technologies (BIAF) reported Net Margin of 268.63% for Q1 2026, down 12510.0% year-over-year from N/an in Q1 2025, and down 36.38% quarter-over-quarter from 196.98% in Q4 2025.
bioAffinity Technologies (BIAF) Net Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of Net Margin data on file, last reported at 268.63% in Q1 2026.
- Net Margin for Q1 2026 came in at 268.63%, down 12510.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 280.57% (down 17002.0% YoY), and the FY2025 annual result was 241.96%, down 14541.0% from the prior year.
- Net Margin eased to 268.63% in Q1 2026 per BIAF's latest filing, from 196.98% in the prior quarter.
- Over five years, Net Margin peaked at 81.53% in Q1 2024 and troughed at 427778.96% in Q3 2022.
- A 5-year average of 42730.41% and a median of 294.25% in 2025 frame the typical range for Net Margin.
- On a YoY basis, Net Margin climbed as much as 42701145 bps in 2023 and fell as far as 207425 bps in 2023.
- A 5-year view of Net Margin shows it stood at 71380.35% in 2022, then surged by 100 bps to 107.22% in 2023, then fell by 25 bps to 134.4% in 2024, then slumped by 47 bps to 196.98% in 2025, then sank by 36 bps to 268.63% in 2026.
- Business Quant data shows BIAF's Net Margin at 268.63% in Q1 2026, 196.98% in Q4 2025, and 349.3% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -5.68% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 15.06% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 17.29% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 24.41% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 18.47% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.22% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.40% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 12.28% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.89% |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | -268.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268.63% |
| Dec 31, 2025 | -196.98% |
| Sep 30, 2025 | -349.30% |
| Jun 30, 2025 | -319.88% |
| Mar 31, 2025 | -143.53% |
| Dec 31, 2024 | -134.40% |
| Sep 30, 2024 | -85.13% |
| Jun 30, 2024 | -88.01% |
| Mar 31, 2024 | -81.53% |
| Dec 31, 2023 | -107.22% |
| Sep 30, 2023 | -767.51% |
| Jun 30, 2023 | -8,816.36% |
| Mar 31, 2023 | -166,426.71% |
| Dec 31, 2022 | -71,380.35% |
| Sep 30, 2022 | -427,778.96% |
| Jun 30, 2022 | -6,742.11% |